Delta Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Delta Capital Management's DGX Position: Q2 2026 in Review
Delta Capital Management increased its Quest Diagnostics (DGX) stake by 0.73% in Q2 2026, buying an estimated $25.5K and bringing the position to 17,940 shares worth $3.8M. The position accounts for 1.75% of the portfolio, ranked #17.
Delta Capital Management first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.13M in Q4 2021. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Delta Capital Management held 17,940 shares of Quest Diagnostics worth $3.8M as of Q2 2026.
- Delta Capital Management bought 130 Quest Diagnostics shares in Q2 2026, an estimated $25.5K.
- Quest Diagnostics made up 1.75% of Delta Capital Management's portfolio in Q2 2026, its #17 holding.
- Delta Capital Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
- Delta Capital Management's Quest Diagnostics position peaked at $4.13M in Q4 2021.
- 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Delta Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.